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Introduction:  Deep  periprosthetic  infection  is  one  of  the most  serious  complications  after  total  knee
replacement.  The  two-stage  procedure  with  implantation  of a  temporary  cement  spacer  and  later  re-
implantation  of  a revision  total  knee  prosthesis  is  an  accepted  procedural  standard.  The  use  of  articulating
spacers  has  been  proposed  to enhance  ease  of revision  and  functional  results.
Patients and  methods:  Twenty-three  patients  treated  with  an  articulating  spacer  were  retrospectively
studied.  All patients  had  undergone  a two-stage  surgery.  The  infected  prosthesis  was  explanted  and
the  femoral  component  was sterilized  and  re-implanted.  On the tibial  side  a  block  of  gentamicin-loaded
bone  cement  was  produced  intraoperatively  using  specially  manufactured  templates.  Eighteen  total  knee
arthroplasty  revisions  and  5  arthrodesis  were  ﬁnally  performed.
Results:  A  total  of three  (13%)  re-infections  occurred  5–20  months  after  revision  total  knee  arthroplasty
in  a mean  follow-up  period  of 47  months.  Prior  to re-implantation,  ﬂexion  with  the  articulating  spacer
◦ ◦ranged  between  15  and  100 (mean  68  ± 28 ). The  average  postoperative  ﬂexion  after re-implantation  of
total  knee  replacement  was  105 ± 11◦.
Conclusion:  The  articulating  spacer  used  in  this  study  appears  to be  as effective  as the  standard  procedures
in  terms  of  re-infection  risk  rate  and  postoperative  range  of  motion  recovery.
Level  of evidence:  Level  IV.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Deep periprosthetic infection is one of the most serious com-
lications after total knee arthroplasty. The treatment is difﬁcult,
nd the postoperative results after re-implantation of a total knee
rosthesis (TKP) are usually worse than after aseptic revision
1,2]. The two-stage procedure with removal of the prosthesis,
mplantation of an antibiotic-impregnated spacer and subsequent
e-implantation of a revision TKP has become an established
ethod of treatment. Success rates vary between 88 and 98% [2–9].
ther methods such as lavage, debridement and antibiotic ther-
py or a single-stage procedure with exchange of the prosthesis in
ate and chronic infections usually do not show these success rates
10–13]. However, use of non-articulating cement spacers results in
estricted mobility and instability of the knee because of prolonged
mmobilization., leading to limited function [5,9,14]. Moreover,
mplanting a revision TKP in patients with a non-articulating spacer
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877-0568/© 2014 Elsevier Masson SAS. All rights reserved.is a more difﬁcult procedure, because of scar tissue, which, for
example, makes osteotomy of the tuberosity or a quadriceps snip
necessary, and because of greater bone loss when using a static as
opposed to an articulating spacer [6,8]. In addition, patients with a
static spacer are more likely to suffer wound healing disorders and
thrombosis [15,16]. Therefore, the system of an articulating cement
spacer was developed in which the femoral component of the pri-
mary TKP is re-sterilized and then re-implanted. Hofmann et al.
replaced the tibial component with a cement spacer and used also
a PE-inlay [8,17]. Fehring et al. used also an articulating spacer but
they used a cement spacer to replace both the femoral and tibial
components [6]. The advantage of this method lies in the consid-
erable improvement in the range of motion of the knee joint and
the increased mobility of patients [3,8,17]. Re-implantation of a
revision TKP therefore leads to a better functional outcome [5].
We retrospectively analyzed 23 patients treated with an
articulating cement spacer without a PE-inlay because of deep
periprosthetic infection after total knee arthroplasty. The aim of
this study was to analyze to what extent the postoperative range of
motion and re-infection rates differ in comparison to other meth-
ods of treatment. We  hypothesized that the postoperative range of
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Table 1
Pathogen spectrum of the infected total knee arthroplasty.
Pathogen spectrum
Staphylococci 13
Streptococci 4
Serratia 1
Escherichia coli 1
Gemella morbillorum 1
Haemophilus parainﬂuenzae 1
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rely on previous examinations. The other patients presented in our
clinic and we were able to carry out a follow-up examination.Propionibacterium spec. 1
Enterococcus faecalis 1
otion would be as good as articulating cement spacer with a PE-
nlay and better as with static spacer. Re-infection rates should be
maller as with articulating cement spacer with a PE-inlay because
f the missing foreign material.
. Patients and methods
Approval was obtained from the Ethics Committee of the Med-
cal Faculty of the University of Duisburg-Essen (Ethics Number:
8-3883). A total of 23 consecutive patients (17 women  and 6
en; mean age: 66 years [37–81 years] at the time of primary
mplantation) treated in our clinic between 2003 and 2008 with an
rticulating spacer because of deep periprosthetic infection were
nalyzed retrospectively. All deep periprosthetic infection after
otal knee arthroplasty that occurred more than 6 weeks after pri-
ary implantation were treated with the method described. The
nfection was conﬁrmed by a positive microbiologically culture.
hese were mainly from the Staphylococcus group (n = 13), followed
y Streptococci group (n = 4) and other pathogen species (Table 1).
The average implant survival rate of the primary prosthesis was
 years (3 months–20 years), so that the average age of the patients
t the time of explantation was 71 years (41–83 years).
The surgical procedure included removal of the tibial and
emoral components. Furthermore, all the cement remnants were
emoved and extensive debridement as well as jet-lavage was
erformed. Then the femoral component was re-sterilized using
lasma sterilization and re-implanted. A tibial plateau of the nec-
ssary thickness was formed of bone cement (PMMA: revision bone
ement with 2% gentamicin sulfat [Palacos® R + G, Heraeus Medi-
al]) using a specially made silicone mould. To avoid greater bone
oss in the next operation the bone cement used to ﬁx the femoral
omponent and the tibial spacer hardened lightly for about 5 to
 minutes so that it was viscous enough not to ﬁx deeply with the
one. Antibiotics according to the patients’ antibiograms were not
dded. A PE-inlay was not used (Figs. 1 and 2). Postoperatively,
atients were mobilized on forearm crutches with their knee sta-
ilized in an orthesis ﬁxating the knee in extension and with foot
ole contact. In addition, passive mobilization of the knee was  per-
ormed under the supervision of a physiotherapist.
After implantation of the spacer the patients received intra-
enous antibiotics according to their antibiogram for two weeks.
hese were then continued for another four weeks orally. There-
fter, the antibiotics were discontinued for two weeks and then the
nee joint was punctured. If the microbiologically cultures and the
ell count were without pathological ﬁndings and CRP levels were
nder 3 mg/dl (normal range: 0.01 to 0.5 mg/dl), a revision total
nee prosthesis was re-implanted or arthrodesis was  performed.
The articulating spacer was left in situ for a mean period of
84 days (76–359 days). The longer period in situ in some of the
ases was not due to surgical reasons, but was related to other dis-
ases of the patients. The average period between re-implantation
nd follow-up examination of re-infection was 47 months (19–103
onths). The average period between re-implantation of revisionFig. 1. A-P radiograph of the knee with an articulating spacer.
TKP and follow-up examination of postoperative range of ﬂexion
was 9.5 months (1.5–58 months).
We investigated any co-morbidities of the patients that may
have had an inﬂuence on immune defense and wound healing,
and determined the Charlson Comorbidity Score [18]. Also any
postoperative complication was  noted as well as the bone defects
described in the surgical report.
Eight of the patients, who  are no longer undergoing treatment in
our clinic, were interviewed by telephone to ﬁnd out if the revision
total knee replacement was  still in situ or if there had been a re-
infection in the meantime. Since we  were not able to investigate the
range of motion of these patients at the latest follow-up, we  had toFig. 2. Lateral radiograph of the knee with an articulating spacer.
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Table 2
Primary and secondary pathogens of the three re-infections.
Primary pathogen Secondary pathogen
-haem. Streptococcus (r) Staphylococcus epidermidis (s)
Gemella morbillorum (r) Proteus mirabilis (s)
because of extensive cicatrisation and patella baja. PostoperativeFig. 3. Flow chart of the postoperative course of the 23 infected TKP.
The data were collected in an Excel ﬁle (Microsoft Corp., Red-
ond, USA) and then examined with regard to means and standard
eviation.
. Results
.1. Technique
Overall, 18 revision TKP (3 hinged total knee prostheses) and ﬁve
rthrodesis nails were implanted (3 because of large bone defects
nd 2 after failure of TKP revision) (Fig. 3). Intraoperatively there
ere no new bone defects at the time of re-implantation compared
o the implantation of the articulating spacer. Only one patient had
n infraction of the dorso-medial part of the tibia at the time of
mplantation of the articulating spacer. This dorso-medial part of
he tibia had been bursted out up to the re-implantation.
During re-implantation of the revision TKP, tuberosity
steotomy was performed in three patients. In one patient
his was because the spacer had already been exchanged once
efore because the surgeon had intraoperatively discovered signs
f infection (see below). The second patient had a patella baja
nd severe chronic polyarthritis. In this case the spacer had also
islocated after a fall on the knee, so the patient was treated with a
ecron orthosis. In the third patient a superﬁcial wound revision
ad to be performed with the spacer in situ while the patient was
till in hospital because of disturbed wound healing. Here also the
icatrization was too extensive.
.2. Infectious results
In two patients the spacer was exchanged at the planned
e-implantation of a revision TKP because the surgeon discov-
red intraoperatively signs of infection. However, in neither of
he patients was proof of the presence of pathogens found in
he preoperative puncture nor in the intraoperative swab and
istopathological examination. Furthermore, the patients’ inﬂam-
atory markers were within the normal range (CRP: 1.35 and
.11 mg/dl, leukocytes: 10.4 and 9.1 T/l).
In three patients (13%) re-infection occurred after 5, 9 and 20
onths after re-implantation of a revision TKP. In all three patients
he pathogen was different from the one found in the primary infec-
ion (primary pathogen) (Table 2). Two of the three patients with
e-infection had co-morbidities (obesity, coronary heart disease,
OPD, emphysema, myocardial infarction, peripheral vascular dis-
ase and chronic renal failure).Staphylococcus epidermidis (s) Enterococcus faecalis (r)
r: resistant to gentamicin; s: sensitive to gentamicin.
3.3. Range of motion
The preoperative range of ﬂexion with the primary TKA was on
average 79 ± 27◦ (10–115◦). The extension deﬁcit was  5 ± 7◦. The
range of motion of the knee for ﬂexion, with the spacer in situ,
was on average 68 ± 28◦ (15–100◦) with a mean extension deﬁcit
of 4 ± 5◦. The postoperative range of ﬂexion with the remaining 18
revision TKP was on average 105 ± 11◦ (80–130◦) (Table 3).
4. Discussion
Articulating spacers are usually implanted according to the
method described by Hofmann et al. [8,17]. The femoral compo-
nent is re-sterilized and a new PE-inlay is inserted which rests on
the tibial cement block. Re-sterilized femoral components, how-
ever, have been shown to have a signiﬁcant advantage regarding the
later range of ﬂexion compared to static spacers, and no signiﬁcant
differences in the re-infection rate have been found [5].
In the present study the femoral component was also re-
sterilized and then re-implanted. However, no PE-inlay was used
and the tibial cement block was formed in a silicone mould
made specially for this purpose. With this system an articulating
spacer is used in combination with a re-sterilized femoral com-
ponent, thus providing the previously described advantages. It is
important that patients are informed explicitly about the use of a
re-sterilized femoral component, because the prosthesis is not pri-
marily intended for this purpose and therefore not approved. This
procedure constitutes an individual attempt to heal the patient’s
infection. As mentioned before, we do not use a PE-inlay, as addi-
tional foreign material increases the risk of bacterial colonization.
The theoretical advantage of our system could not be proved in
this study because the re-infection rate is 13% and therefore at
a similar level to that in previous studies (4–12%) with a similar
pathogen spectrum and using a PE-inlay [3,5,6,8]. However, in this
study the primary pathogen was not detected in any of the re-
infections. The new infection was  caused by a different pathogen
in every case. The detection of different pathogens at re-infection
is already known from previous studies dealing with the articulat-
ing spacer [2,5,7,8]. In most studies, as well as re-infections with
different pathogens, there were also re-infections with the same
pathogen. Only one study reported re-infections which were all due
to different pathogens [5]. Therefore, the secondary infection may
be a recurrence of the primary infection which was a mixed infec-
tion or it may  be a completely new infection. At the time of the study
only one puncture and two swabs of the explanted components was
made intraoperatively in our clinic. Today it is established to take
at least ﬁve samples for microbiological analysis.
Other studies show that the risk for wound healing disorders,
thrombosis, bone loss and extensive cicatrization is greater when
using a static spacer [6,8,15,16]. Nevertheless in this study there
was one patient with disturbed wound healing so that a superﬁcial
wound revision had to be performed. In three patients a tuberos-
ity osteotomy has to be performed at the time of re-implantationthrombosis or greater bone loss did not occur in the time the artic-
ulating spacer was  in situ. The bone loss should be reduced by using
cement that lightly hardened for about 5 to 6 minutes so that it
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Table 3
Articulating spacer: literature review.
References Number of
patients
Re-infection (%) Re-infection with
the same pathogen
Range of ﬂexion with spacer
[average (maximum ﬂexion)]
Postoperative range of ﬂexion
[average (maximum ﬂexion)]
Follow-up
(months)
Anderson et al. [3] 25 1 (4%) 1 112 115 54 (24–108)
Cuckler [4] 44 1 (2,3%) 1 110 (45–125) 112 (45–125) 65 (24–120)
Haddad et al. [7] 45 4 (8,9%) 1 71,2 (10–130) 94,5 (20–135) 48 (20–112)
Hofmann et al. [8] 50 6 (12%) 2 91 104 73 (24–150)
Hofmann et al. [17] 26 0 0 82 106 31 (12–70)
Park  et al. [19] 16 1 (6,3%) ? 80 (50–140) 108 (85–140) 29 (25–45)
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[
[Pietsch et al. [20] 33 3 (9,1%) 1 
Present study 23 3 (13%) 0 
s viscous enough not to ﬁx deeply with the bone. So it is possi-
le to get the spacer out without any bone loss. At the same time
he connection between cement and bone is not stable enough for
eight bearing. Therefore the patients were mobilized on forearm
rutches with their knee stabilized in an orthesis ﬁxating the knee
n extension and only with foot sole contact.
The maximum range of ﬂexion with the articulating spacer in
he present study was between 15–100◦. Previous studies showed
 range of ﬂexion of between 10–130◦ with the spacer in situ. The
ostoperative range of ﬂexion after implantation of a revision TKA
105◦) was also similar to that of previous studies (between 94.5
nd 115◦) [3,4,7,8,17–20].
In our opinion there is no need for the implantation of a PE-
nlay because it has no advantage. Although we cannot prove it in
he end as part of this study the implantation of the PE-inlay could
e a further target for pathogens. The functional results without the
E-inlay are as good as these of previous studies with PE-inlay.
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